Innoviva, Inc. Files 8-K on Shareholder Matters
Ticker: INVA · Form: 8-K · Filed: Jun 20, 2024 · CIK: 1080014
| Field | Detail |
|---|---|
| Company | Innoviva, INC. (INVA) |
| Form Type | 8-K |
| Filed Date | Jun 20, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote, 8-k
TL;DR
Innoviva held a shareholder vote on June 17th. Details filed June 20th.
AI Summary
Innoviva, Inc. filed an 8-K on June 20, 2024, reporting on matters submitted to a vote of its security holders as of June 17, 2024. The filing details the company's corporate structure, including its incorporation in Delaware and its principal business address in Burlingame, California.
Why It Matters
This filing indicates that Innoviva, Inc. held a vote of its security holders, which is a standard corporate governance event that can impact company direction and shareholder rights.
Risk Assessment
Risk Level: low — This is a routine 8-K filing related to corporate governance and shareholder votes, not indicating any immediate financial distress or significant operational changes.
Key Players & Entities
- Innoviva, Inc. (company) — Registrant
- June 17, 2024 (date) — Date of earliest event reported
- June 20, 2024 (date) — Date of report
- Delaware (jurisdiction) — State of Incorporation
- 1350 Old Bayshore Highway, Suite 400, Burlingame, California 94010 (address) — Business Address
FAQ
What specific matters were submitted to a vote of Innoviva, Inc.'s security holders?
The filing states that the report concerns 'Submission of Matters to a Vote of Security Holders' but does not specify the exact proposals voted upon in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on June 17, 2024.
What is Innoviva, Inc.'s Commission File Number?
Innoviva, Inc.'s Commission File Number is 000-30319.
In which state is Innoviva, Inc. incorporated?
Innoviva, Inc. is incorporated in Delaware.
What is the principal business address of Innoviva, Inc.?
The principal business address is 1350 Old Bayshore Highway, Suite 400, Burlingame, California 94010.
Filing Stats: 554 words · 2 min read · ~2 pages · Grade level 8.5 · Accepted 2024-06-20 16:30:13
Key Financial Figures
- $0.01 — ch registered Common Stock, par value $0.01 per share INVA The NASDAQ Global Se
Filing Documents
- tm2417565d1_8k.htm (8-K) — 33KB
- 0001104659-24-073416.txt ( ) — 202KB
- inva-20240617.xsd (EX-101.SCH) — 3KB
- inva-20240617_lab.xml (EX-101.LAB) — 33KB
- inva-20240617_pre.xml (EX-101.PRE) — 22KB
- tm2417565d1_8k_htm.xml (XML) — 4KB
07
Item 5.07. Submission of Matters to a Vote of Security Holders. At the Annual Meeting of Stockholders held on June 17, 2024 (the "Meeting"), the stockholders of Innoviva, Inc. ("Innoviva") elected six members to our board of directors, each for a one-year term expiring at the annual meeting of stockholders in 2025, as follows: Members Number of Shares Voted For Number of Shares Voted Against or Abstained Broker Non- Votes Mark DiPaolo, Esq. 52,630,405.53 1,369,108 2,544,371.42 Jules Haimovitz 52,638,945.53 1,360,568 2,544,371.42 Odysseas D. Kostas, M.D. 53,558,321.53 441,192 2,544,371.42 Sarah Schlesinger, M.D. 52,024,328.53 1,975,185 2,544,371.42 Derek Small 53,731,768.53 267,745 2,544,371.42 Sapna Srivastava, Ph.D. 48,313,815.53 5,685,698 2,544,371.42 At the Meeting, our stockholders next approved on a non-binding advisory basis, Innoviva's executive compensation. The vote for such approval was 52,833,150.39 shares for, 1,146,788 shares against, 19,575.14 shares abstaining, and 2,544,371.42 shares of broker non-votes. Also at the Meeting, our stockholders next ratified the selection by the Audit Committee of the Board of Directors of Innoviva of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024. The vote for such ratification was 56,265,724.95 shares for, 271,022 shares against, 7,138 shares abstaining and 0 broker non-votes. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INNOVIVA, INC. Date: June 20, 2024 By: /s/ Pavel Raifeld Pavel Raifeld Chief Executive Officer